ReShape Lifesciences, Inc. (RSLS) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Vyome Holdings, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.109 -- 00:00:04.171 Good day, and thank you for standing by. Welcome to the 00:00:04.171 -- 00:00:08.513 Reshape Life Sciences second quarter 2024 earnings call. 00:00:08.513 -- 00:00:11.854 At this time, all participants are on a listen-only mode. 00:00:11.854 -- 00:00:14.255 Please be advised that today's conference is being recorded. 00:00:14.255 -- 00:00:18.817 I would now like to hand the conference over to your speaker today, Michael Miller, RX 00:00:18.817 -- 00:00:22.078 Communications. Please go ahead. 00:00:22.199 -- 00:00:26.540 Good afternoon, and thank you for joining the second quarter 2024 Reshape 00:00:26.540 -- 00:00:30.985 Life Sciences earnings call. I'm pleased to be joined today by Paul Hickey, President 00:00:30.985 -- 00:00:35.628 and Chief Executive Officer, and Tom Stankovich, Chief Financial Officer. 00:00:35.628 -- 00:00:40.551 Management will also be joined by Krishna Gupta, a current director of IOM Therapeutics, 00:00:40.551 -- 00:00:45.014 who will be appointed chairman of the combined company upon the completion of the previously 00:00:45.014 -- 00:00:48.876 announced merger agreement between the two companies. 00:00:48.876 -- 00:00:53.713 As we do each quarter, Paul will provide an overview and update on the company's activities, 00:00:53.713 -- 00:00:58.237 and Tom will review the financial results for the period, after which Paul will introduce 00:00:58.237 -- 00:01:03.381 Krishna for his remarks. As a reminder, this conference call, as well as Reshape Life 00:01:03.381 -- 00:01:08.305 Sciences SEC filings and website, including the investor 00:01:08.305 -- 00:01:12.028 information section of the website, contain forward-looking statements within the meaning 00:01:12.028 -- 00:01:15.811 of the Private Securities Liti...